Stock PRLD PRELUDE THERAPEUTICS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Prelude Therapeutics Incorporated

Equities

PRLD

US74065P1012

Delayed Nasdaq
Other stock markets
 15:57:08 14/05/2024 BST 		5-day change 1st Jan Change
4.02 USD +5.79% Intraday chart for Prelude Therapeutics Incorporated +8.65% -5.85%
05-07 Prelude Therapeutics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-10 Bryant D. Lim to Serve as Principal Financial Officer and Principal Accounting Officer of Prelude Therapeutics Incorporated CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bryant D. Lim to Serve as Principal Financial Officer and Principal Accounting Officer of Prelude Therapeutics Incorporated
CI
Insider Buy: Prelude Therapeutics
MT
Deborah Morosini Resigns as an Officer of Prelude Therapeutics Incorporated and Will Transition into a Role of Strategic Advisor to the President
CI
Prelude Therapeutics Incorporated Appoints Jane Huang as President and Chief Medical Officer, Effective April 4, 2022
CI
Prelude Therapeutics Incorporated Announces Management Changes
CI
Prelude Therapeutics Incorporated Announces Resignation of Christopher Pierce as Executive Vice President and Chief of Business Operations, Effective on September 30, 2021
CI
Insider Sell: Prelude Therapeutics
MT
Insider Sell: Prelude Therapeutics
MT
Prelude Therapeutics Incorporated Appoints Michele Porreca as Chief People Officer
CI
Prelude Therapeutics Appoints Martin Babler to its Board of Directors
CI
Prelude Therapeutics Incorporated Announces Board Changes
CI
Prelude Therapeutics Announces Board Appointments
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PRLD Stock
  4. News Prelude Therapeutics Incorporated
  5. Insiders